November 09, 2022
A group of drug purchasers and state-level enforcers accusing generic-drug manufacturers of fixing prices asked a Pennsylvania federal court on Tuesday to allow it to depose a former top executive who was indicted on criminal antitrust charges ahead of his trial.
June 07, 2022
The Pennsylvania federal judge overseeing sprawling price-fixing litigation against generic-drug makers on Tuesday tossed a disgorgement claim brought by state attorneys general, but kept alive their claim for injunctive relief.
May 25, 2022
A Pennsylvania federal judge dismissed, for now, indirect generic-drug resellers' price-fixing claims levied against distributors like McKesson Corp. as a part of multidistrict litigation, ruling Wednesday that the plaintiffs failed to sufficiently allege a conspiracy.
May 20, 2022
Mylan and other pharmaceutical companies facing allegations of price-fixing for generic drugs told a Pennsylvania federal judge overseeing multidistrict litigation that the Pennsylvania Attorney General's Office has refused to produce key documents.
May 11, 2022
Deals for three generic-drug companies to fork over a combined $86 million to direct purchasers and indirect resellers to settle price-fixing allegations gained preliminary approval from a Philadelphia federal judge Wednesday.
May 10, 2022
A Pennsylvania federal court denied a dismissal bid Tuesday from drug companies in sprawling multidistrict litigation over alleged generic drug price-fixing, refusing to toss some state claims from end-payors while rejecting arguments that intervening authority should result in the claims being nixed.
April 07, 2022
After last week's $1.45 million settlement with Louisiana's attorney general, a pattern is emerging in Teva's efforts to deal its way out of sprawling price-fixing litigation that could put the generic-drug maker on the hook for about $100 million if it settles with every state enforcer.
March 16, 2022
Generic-drug buyers on Wednesday asked a Pennsylvania federal court to certify a settlement class and preliminarily approve settlements with Sun Pharma and Taro Pharmaceuticals worth a combined $85 million, the first on behalf of any private plaintiff in sprawling multidistrict litigation over alleged price-fixing of generic drugs.
March 09, 2022
Generic-drug buyers urged a Pennsylvania federal judge Tuesday not to consider a dismissal bid from pharmaceutical companies more recently added to multidistrict price-fixing litigation, arguing the motion was filed in violation of an agreement to tackle bellwether cases first.
November 05, 2021
Two U.S. subsidiaries of Indian drugmaker Sun Pharma have agreed to shell out a combined $85 million to a proposed class of direct purchaser plaintiffs in sweeping multidistrict litigation over alleged price-fixing of generic drugs, the companies have reportedly disclosed.